552.760 609.636 l S 40 0 obj /Subtype /Link

0.578 w [ ] 0 d BT 42.520 690.556 Td 0.000 Tw /F1 11.0 Tf 0 Tr (treatment with high-dose steroids, alkylating agents or antimetabolites, or in ) Tj ET q BT 42.520 180.760 Td 0.000 Tw /F1 11.0 Tf 0 Tr (Following nasal administration, \(t\)ransmission of the \(influenza\) vaccine ) Tj ET BT 42.520 629.288 Td 0.000 Tw /F1 11.0 Tf 0 Tr ( endobj /A 178 0 R BT 42.520 524.092 Td 0.000 Tw /F1 11.0 Tf 0 Tr ( BT 425.197 657.032 Td 0.000 Tw /F1 10.0 Tf 0 Tr (110-119) Tj ET

/S /URI 0.000 0.000 1.000 RG

For information on the expected reaction following successful vaccination with BCG Vaccine AJV, see section 4.8. Tj ET /Rect [425.1969 667.4977 430.7569 679.0577 ] BT 425.197 565.708 Td 0.000 Tw ET 191 0 obj /URI (http://www.who.int/immunization/wer7840yellow_fever_Oct03_position_paper.pdf)

/URI (http://www.who.int/wer/2004/wer7903.pdf) BT 425.197 247.808 Td 0.000 Tw ET 552.760 609.636 l S BT 42.520 400.400 Td 0.000 Tw /F1 11.0 Tf 0 Tr (only, particularly in the elderly. 425.197 531.317 m 425.197 370.633 m ) Tj ET

/Subtype /Link << /Type /Annot /A 412 0 R q 236 0 R

425.197 310.521 m BT 42.520 507.908 Td 0.000 Tw /F1 11.0 Tf 0 Tr (temperature below 38.5C;

endobj 0.000 0.000 1.000 RG BT 42.520 516.000 Td 0.000 Tw /F1 10.0 Tf 0 Tr (

) q BT 42.520 643.160 Td 0.000 Tw /F1 11.0 Tf 0 Tr ( 1 w Tj ET
/URI (http://www.who.int/immunization/wer7532typhoid_Aug00_position_paper.pdf) /Border [0 0 0]

/S /URI BT 42.520 715.988 Td 0.000 Tw /F1 11.0 Tf 0 Tr (centres is likely to promote the appropriate use of YF vaccine.) /S /URI >> /URI (http://www.who.int/entity/wer/2007/wer8249_50.pdf) << /Type /Annot << /Type /Annot /A 108 0 R BT 42.520 626.976 Td 0.000 Tw /F1 11.0 Tf 0 Tr ( Q Furthermore, care should be taken that routine yellow fever ) Tj ET /URI (http://www.who.int/immunization/wer7914measles_April2004_position_paper.pdf) /A 288 0 R /Subtype /Link /H /I BT 42.520 497.504 Td 0.000 Tw /F1 11.0 Tf 0 Tr ( /Name /F2

/URI (http://whqlibdoc.who.int/hq/2000/WHO_V&B_00.05.pdf) ) Tj ET >> 0000107847 00000 n /Parent 3 0 R 0.578 w [ ] 0 d 425.197 642.293 l S BT 42.520 387.684 Td 0.000 Tw /F2 14.0 Tf 0 Tr (Policy) Tj /F1 14.0 Tf 0 Tr (

550 0 obj Q /Subtype /Link 140 0 obj /Annots [ 259 0 R 261 0 R 263 0 R 265 0 R 267 0 R 269 0 R] BT 42.520 452.420 Td 0.000 Tw /F2 11.0 Tf 0 Tr (Yellow fever vaccine \(WHO position paper\)) Tj /F1 11.0 Tf 0 Tr (

BT 42.520 267.460 Td 0.000 Tw /F1 11.0 Tf 0 Tr (reactions to any of the vaccines components. /Rect [425.1969 416.6457 425.1969 428.2057 ] INDICATIONS AND USAGE . 0.578 w [ ] 0 d BT 42.520 355.316 Td 0.000 Tw /F1 11.0 Tf 0 Tr (years on long-term aspirin therapy, pregnancy during the first trimester, and ) Tj ET /URI (http://www.who.int/immunization/wer7645mumps_Nov01_position_paper.pdf) /Subtype /Link 0.578 w [ ] 0 d /H /I
>> BT 425.197 725.236 Td 0.000 Tw /F1 10.0 Tf 0 Tr (page 166) Tj ET 0.578 w [ ] 0 d ) Tj ET